Truly Co-Founders Present at the Biomaterials International 2023 Conference in Sapporo, Japan

July 31st, 2023

At the Biomaterials International 2023 Conference, Truly Technologies co-founders James Lai PhD., Samuel Chen, and Abe Wu shared recent progress on Truly’s osmotic sample processing device that concentrates urinary biomarkers for rapid and sensitive diagnosis of active tuberculosis disease.

Sam and Abe present on “Osmotic Concentration of Urinary Lipoarabinomannan for Rapid and Sensitive Detection of Tuberculosis” and answer questions from an international audience of diverse scientific, engineering and clinical backgrounds.

James shares bioprocessing technologies developed in his laboratory for enhancing biomarker analysis.